optogenetics

Stanford neuroscientist Karl Deisseroth has been awarded the 2026 Nobel Prize in physiology or medicine. Deisseroth, known as a pioneer of optogenetics — a technique that uses light to control brain cells — spoke about receiving the honour. The announcement is drawing wide attention from scientists and the public, with strong engagement across social platforms discussing the award and its significance for neuroscience research.

Karl Deisseroth, the Stanford bioengineer and psychiatrist known for pioneering optogenetics, sits for an interview featured by the Nobel Prize organisation. He is expected to discuss his groundbreaking work on light-based control of brain cells and its impact on neuroscience and mental health research. The conversation is drawing attention from scientists and followers of the Nobel announcements worldwide.

Karl Deisseroth, a US-based neuroscientist, has been named a winner of the 2026 Nobel Prize in Physiology or Medicine, awarded for work on optogenetics, a technique that uses light to study and control brain circuits. He shares the prize with American and German scientists, and media worldwide are covering the breakthrough and the laureates' stories.

Karl Deisseroth, Peter Hegemann and Georg Nagel have been awarded the Nobel Prize in Physiology or Medicine. The trio is recognised for developing optogenetics, a technique that uses light to control the activity of nerve cells, which has transformed the study of the brain. The announcement, reported by RFI, is drawing wide attention in France and internationally.

The 2025 Nobel Prize in Physiology or Medicine went to three researchers from the US and Germany, including Stanford professor Karl Deisseroth, for their work on optogenetics, a technique that uses light to control nerve cells. Japanese media highlighted the award, noting the pioneering nature of the research and the connection of a Tokyo University professor described as Deisseroth's senior colleague in the field.

Karl Deisseroth, along with Peter Hegemann and Ernst Nagel, has been awarded the Nobel Prize in Physiology or Medicine for their work on optogenetics, a technique that uses light to control brain cells. The Science Media Centre España highlighted the award, and the news is drawing attention across several countries.

The Nobel Prize in Physiology or Medicine has been awarded to three scientists for their work on brain activity, with Stanford researcher Karl Deisseroth drawing wide attention alongside the laureates. Deisseroth is known for pioneering optogenetics, a technique that allows specific brain cells to be controlled with light. The announcement is generating discussion worldwide, with the award also trending in Sweden and Germany.

The Nobel Prize in Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel, honouring their work on optogenetics, a technique that uses light to control nerve cells. The trio's findings opened new ways to study and treat brain disorders. German media, including Der Spiegel, are covering the announcement.

Karl Deisseroth, Peter Hegemann and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine for their work on optogenetics, a technique that uses light to control the activity of nerve cells. The method, built on light-sensitive proteins, transformed brain research and is widely used to study conditions such as Parkinson's disease and depression.

Stanford University announced that Karl Deisseroth has won the Nobel Prize. The psychiatrist and bioengineer is known for pioneering optogenetics, a technique that uses light to control brain cells. News of the award is drawing attention across the scientific community, with congratulations coming in for the Stanford researcher.

Karl Deisseroth, Peter Hegemann and Georg Nagel have won this year's Nobel Prize in Physiology or Medicine for developing optogenetics, techniques for controlling genes with light. Scientists and research organisations, including the Max Planck Society, have congratulated the trio, whose work allows nerve cells to be switched on and off using light and has transformed studies of the brain.

A trio of scientists has been awarded the 2026 Nobel Prize in Physiology or Medicine for optogenetics, a technique that uses light to control cells, including neurons in the brain. Swedish media are covering the announcement widely, with a brain researcher calling the work "groundbreaking". Debate is also under way about which researchers deserved the honour.

Peter Hegemann, the Berlin-based biophysicist who shared the 2012 Nobel Prize for the discovery of light-sensitive channel proteins, is drawing renewed attention. German media feature visits to his high-tech laboratory, while international outlets discuss optogenetics — the 'light switches for brain cells' he helped pioneer — in predictions for the 2026 Nobel Prizes.

Stanford's Karl Deisseroth has been awarded the 2026 Nobel Prize in Physiology or Medicine, prompting wide interest in who shared the honour with him. The announcement has drawn heavy attention in India and globally, with audiences discussing his pioneering work in optogenetics, a technique that uses light to control brain cells and has transformed neuroscience research.

The Nobel Prize in Physiology or Medicine has been awarded for optogenetics, a technique that uses light to control neurons. Scientists are celebrating the recognition of a method that transformed neuroscience, enabling precise manipulation of brain circuits and advancing research into conditions such as Parkinson's disease, epilepsy and depression.

A Nobel Prize has been awarded for work on optogenetics, the technique that uses light to control brain cell activity. The method, which lets researchers switch specific neurons on and off with pulses of light, has transformed the study of brain circuits and is being explored for treating conditions such as Parkinson's disease and blindness. Scientists have long considered the field a leading candidate for the award.

The Nobel Prize has been awarded for optogenetics, a technique that uses light to control neurons, recognised as a major breakthrough in neuroscience. Writing in The Conversation, commentators describe it as one of a series of technological innovations helping scientists map and control the brain, opening new paths for studying and potentially treating neurological conditions.

Optogenetics, a technique that lets scientists control brain cells with light, has been awarded the Nobel Prize. Commenters describe it as one in a line of technological innovations — from MRI to connectome mapping and AI — that are transforming neuroscience and giving researchers new ways to map and manipulate the brain. The award is being hailed as recognition of how engineering tools and biology together are reshaping medicine and brain science.

The 2026 Nobel Prize in Medicine has been awarded for optogenetics, a technique that lets scientists control brain cells with light. The method has transformed neuroscience by allowing researchers to switch specific neurons on and off in living animals, advancing the study of brain circuits and disorders such as Parkinson's disease. Health outlets are reporting the announcement.

Scientists from the United States and Germany have been awarded the Nobel Prize in Physiology or Medicine for work on how light can be used to study and control brain activity. The findings, honoured by the Nobel Assembly in Stockholm, are widely recognised as foundational for optogenetics, a technique that lets researchers switch specific neurons on and off with light and has transformed modern neuroscience.

Stanford University bioengineer and psychiatrist Karl Deisseroth has been announced as a Nobel Prize winner, according to an announcement from Stanford University. The prize recognizes his work in the field of medicine, where he is best known for pioneering optogenetics, a technique that uses light to control brain cells. Congratulations and discussion of the achievement are spreading widely.

Optogenetics, a technique that lets scientists switch genes and neurons on and off using light, has been awarded the Nobel Prize in Physiology or Medicine. The method, pioneered in part by Stanford's Karl Deisseroth, transformed neuroscience by allowing precise control of brain cells. Commenters recalled the field's early days around 2004, noting how quickly it moved from novel idea to Nobel-recognised breakthrough.

Psychiatrist and author Karl Deisseroth, published by Random House, has been awarded the 2025 Nobel Prize in Physiology or Medicine. Deisseroth, a Stanford researcher, is known for pioneering optogenetics and for his book 'Projections'. The honor recognizes his contributions to understanding the brain, and readers and scientists alike are congratulating the scientist-author on the recognition.

The Nobel Prize in Medicine has been awarded for optogenetics, a technique that uses light to control brain cells. The method, which combines genetics and optics, allows researchers to switch specific neurons on and off with remarkable precision, transforming the study of brain circuits. Commentators describe it as a landmark advance for neuroscience, with potential implications for understanding and treating conditions such as Parkinson's disease and other neurological disorders.

Stanford bioengineer and psychiatrist Karl Deisseroth has been named the recipient of the 2026 Nobel Prize in Physiology or Medicine, according to an announcement from the Howard Hughes Medical Institute, where he is an investigator. Deisseroth is best known for pioneering optogenetics, a technique that uses light to control neurons and has transformed research into brain circuits underlying behaviour and neurological disease.

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel for their discoveries concerning light-gated ion channels and optogenetics. The technique, which lets scientists control brain cells with light, is widely credited with transforming neuroscience research.

Karl Deisseroth, a 1992 Harvard graduate, has been awarded the Nobel Prize in Medicine. Deisseroth, known for pioneering optogenetics, a technique using light to control brain cells, receives one of science's highest honours. The award is drawing attention among Harvard alumni and the wider neuroscience community, celebrating a career that transformed how researchers study neural circuits and brain-related disorders.

Karl Deisseroth, Peter Hegemann and Georg Nagel have been awarded the Nobel Prize in Physiology or Medicine for developing optogenetics, a technique that controls neurons in the brain using light. Their work began with studies of light-sensitive algae proteins and led to methods for activating and shutting down specific neurons, transforming neuroscience research.

The 2026 Nobel Prize in Physiology or Medicine has been awarded for optogenetics, the technique that lets scientists control brain cells with light. The method traces back to light-sensitive proteins from algae, which researchers adapted to switch neurons on and off with precise beams of light. The approach has transformed neuroscience, allowing researchers to map and manipulate neural circuits in living animals.